Literature DB >> 1758885

Computer design of bioactive molecules: a method for receptor-based de novo ligand design.

J B Moon1, W J Howe.   

Abstract

The design of molecules to bind specifically to protein receptors has long been a goal of computer-assisted molecular design. Given detailed structural knowledge of the target receptor, it should be possible to construct a model of a potential ligand, by algorithmic connection of small molecular fragments, that will exhibit the desired structural and electrostatic complementarity with the receptor. However, progress in this area of receptor-based, de novo ligand design has been hampered by the complexity of the construction process, in which potentially huge numbers of structures must be considered. By limiting the scope of the structure-space examined to one particular class of ligands--namely, peptides and peptide-like compounds--the problem complexity has been reduced to the point that successful, de novo design is now possible. The methodology presented employs a large template set of amino acid conformations which are iteratively pieced together in a model of the target receptor. Each stage of ligand growth is evaluated according to a molecular mechanics-based energy function, which considers van der Waals and coulombic interactions, internal strain energy of the lengthening ligand, and desolvation of both ligand and receptor. The search space is managed by use of a data tree which is kept under control by pruning according to the energy evaluation. Ligands grown by this procedure are subjected to follow-up evaluation in which an approximate binding enthalpy is determined. This methodology has proven useful as a precise model-builder and has also shown the ability to design bioactive ligands.

Mesh:

Substances:

Year:  1991        PMID: 1758885     DOI: 10.1002/prot.340110409

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  46 in total

1.  DREAM++: flexible docking program for virtual combinatorial libraries.

Authors:  S Makino; T J Ewing; I D Kuntz
Journal:  J Comput Aided Mol Des       Date:  1999-09       Impact factor: 3.686

2.  Functional concerted motions in the bovine serum retinol-binding protein.

Authors:  P L Chau; D M van Aalten; R P Bywater; J B Findlay
Journal:  J Comput Aided Mol Des       Date:  1999-01       Impact factor: 3.686

3.  Evaluation of designed ligands by a multiple screening method: application to glycogen phosphorylase inhibitors constructed with a variety of approaches.

Authors:  S S So; M Karplus
Journal:  J Comput Aided Mol Des       Date:  2001-07       Impact factor: 3.686

4.  A genetic algorithm for structure-based de novo design.

Authors:  S C Pegg; J J Haresco; I D Kuntz
Journal:  J Comput Aided Mol Des       Date:  2001-10       Impact factor: 3.686

5.  Discovery of a novel serine protease inhibitor utilizing a structure-based and experimental selection of fragments technique.

Authors:  S Makino; T Kayahara; K Tashiro; M Takahashi; T Tsuji; M Shoji
Journal:  J Comput Aided Mol Des       Date:  2001-06       Impact factor: 3.686

6.  Q-fit: a probabilistic method for docking molecular fragments by sampling low energy conformational space.

Authors:  Richard M Jackson
Journal:  J Comput Aided Mol Des       Date:  2002-01       Impact factor: 3.686

7.  A new method for estimating the importance of hydrogen-bonding groups in the binding site of a protein.

Authors:  Matthew D Kelly; Ricardo L Mancera
Journal:  J Comput Aided Mol Des       Date:  2003-07       Impact factor: 3.686

Review 8.  A review of protein-small molecule docking methods.

Authors:  R D Taylor; P J Jewsbury; J W Essex
Journal:  J Comput Aided Mol Des       Date:  2002-03       Impact factor: 3.686

9.  Development and testing of a de novo drug-design algorithm.

Authors:  Eric Pellegrini; Martin J Field
Journal:  J Comput Aided Mol Des       Date:  2003-10       Impact factor: 3.686

10.  Designing the molecular future.

Authors:  Gisbert Schneider
Journal:  J Comput Aided Mol Des       Date:  2011-11-30       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.